Esperion Therapeutics Stock Soars 19.51% on May 28, 2025

Esperion Therapeutics' stock surged 19.51% in pre-market trading on May 28, 2025, marking a significant rise for the biopharmaceutical company.

Esperion Therapeutics has been experiencing volatility in its stock price, with a 3.75% gain on the last trading day, May 27, 2025. The stock price fluctuated between $0.795 and $0.83 during the day, indicating a high level of intraday volatility. The company's stock has shown a 2.63% gain over the past two weeks, but the overall trend remains bearish with a predicted fall of 52.58% over the next three months.

Esperion Therapeutics has been facing challenges with its stock price, which has been in a falling trend. The company has received several negative signals from both short and long-term moving averages, indicating a bearish outlook. The stock is expected to face resistance at $0.83 and $0.92, and a break above these levels would be necessary for a bullish reversal.

Esperion Therapeutics has been working on addressing its remaining $50 to $55 million tab on convertibles, which could impact its financial stability. The company has developed a strategy to address this, including the potential use of milestone payments. This financial situation could influence investor sentiment and contribute to the stock's volatility.